Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01922674
Other study ID # R01 HS09860 OlAl
Secondary ID 99-11925
Status Completed
Phase N/A
First received August 12, 2013
Last updated April 3, 2018
Start date January 1999
Est. completion date December 2004

Study information

Verified date April 2018
Source Creighton University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Purpose: To determine if observation (watchful waiting is a safe alternative to routine repair of asymptomatic inguinal hernias in adult males.

Scope: Traditionally surgeons are taught that all inguinal hernias should be repaired at diagnosis to prevent the life threatening complications of bowel obstruction or incarceration with strangulation and that operation becomes more difficult the longer a hernia is left un-repaired.


Description:

Screening of potential patients for the trial was conducted on all patients presenting to the surgeon's office with a possible hernia. Unless unequivocal contraindications were present, patients were scheduled to see the participating surgeon to confirm that they were candidates for the study. Informed consent for participation in the trial and for randomization was then obtained. Consent and patient-centered data collection documents were translated into Spanish and French. After the patient provided informed consent and all inclusion criteria were satisfied, the Study Coordinator telephoned the center where the staff confirmed eligibility. The patient was then randomly assigned to either operation or watchful waiting with the randomization stratified by: participating site, whether the hernia is primary or recurrent, and bilateral or unilateral hernia. At the time of screening, an anonymous list was maintained of patients who were not enrolled; reasons for ineligibility or non enrollment were recorded in addition to patient age and categories of co-morbidities, but no names or personal identification items were recorded. These data were used to determine recruitment percentage and whether important differences exist between enrolled and non enrolled patients.

The procedure described by Lichtenstein was the control operation. A videotape by Amid, presented at the 1998 Clinical Congress of the American College of Surgeons, was used as the standard for the Lichtenstein operation. The PIs from each institution reviewed the video at an investigators' meeting before patient recruitment began and details of the procedure were agreed upon; all surgeons participating in the trial were willing to follow the procedure as described. Local anesthesia was recommended but not required.

Several important technical features of the operation were adhered to strictly. The prosthesis had to be a minimum of 15 cm in width and 7.5 cm high and overlap the pubic tubercle onto the anterior rectus sheath. A running, non absorbable monofilament suture was used to secure the inferior border of the prosthesis beginning on the anterior rectus sheath at least 2 cm medial to the pubic tubercle. The suture was continued laterally on either side of the pubic tubercle and then along the shelving edge of the inguinal ligament to the internal ring. Interrupted sutures were used only if it was necessary to incorporate Cooper's ligament into the repair because of extensive destruction of the inguinal floor or a femoral hernia. A slit in the lateral end of the mesh was cut to produce a narrow (1/3-width) tail below and a wider (2/3-width) tail above. The spermatic cord was positioned between the two tails. The inferior surface of the wider tail was sutured to the inferior surface of the narrow one and the shelving edge of the inguinal ligament, thereby creating a shutter valve that acts as a snug-fitting internal ring. This step is considered particularly important to prevent an indirect recurrence. Simple linear reapproximation was not permitted. The tails could be trimmed but a minimum of 6 cm lateral to the internal ring was required. Written postoperative instructions were provided to each patient.

Watchful waiting patients were taught about dangerous hernia symptoms and written instructions and explanations were provided. Subjects were told to contact their physician if problems developed. They were seen in person at 6 months, and yearly after enrollment.

Follow-up: Watchful waiting patients were given written instructions to watch for hernia symptoms and contact their physician if problems developed. Patients were examined at 6 months and yearly after enrollment.


Recruitment information / eligibility

Status Completed
Enrollment 720
Est. completion date December 2004
Est. primary completion date December 2004
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years of age or older (19 years in Nebraska)

- Male

- Diagnosis of inguinal hernia (patients with bilateral and recurrent hernias are eligible)

- Inguinal hernia that is either completely asymptomatic or minimally symptomatic (does not interfere with normal activities

- Informed consent for randomization

Exclusion Criteria:

- A hernia that could not detected on physical examination

- American Society of Anesthesia (ASA) Class IV or V

- Evidence was present of an acute hernia complication such as bowel obstruction, strangulation, peritonitis, or perforation

- Local or systemic infection

- Presence of pain and discomfort associated with the hernia that limits usual activities

- A history of recent (within six weeks of visit) onset of difficulty in reducing a hernia that was previously easily reduced

- Participation in another clinical trial

- Female

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Standard open tension-free inguinal hernia repair with mesh


Locations

Country Name City State
United States Creighton University Omaha Nebraska

Sponsors (9)

Lead Sponsor Collaborator
Creighton University American College of Surgeons, Edward Hines Jr. VA Hospital, Marshfield Clinic Research Foundation, Northwestern University, Royal Victoria Hospital, Canada, University of Nebraska, University of Texas Southwestern Medical Center, VA Salt Lake City Health Care System

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain Pain or discomfort interfering with usual activities two years after enrollment 2 years
Primary Post operative complications Post-operative complications were assessed at the two-week visit and as needed for three months. Long-term complications, including hernia recurrence were assessed at the six-month and annual visits. Life-threatening complications were defined prior to the start of the study and were assessed up to 30 days postoperative. 2 years
Secondary Complications Complications and patient-reported outcomes of pain, functional status, activity levels and satisfaction with care. These were measured at baseline, six months and annually. Pain was also assessed at the time of crossover in watchful waiting patients who received Lichtenstein open tension-free repair. 2 years
See also
  Status Clinical Trial Phase
Terminated NCT00471692 - Local Anaesthetic Following Hernia Repair Phase 1
Completed NCT01842204 - Evaluation of the Efficacy of Electromagnetic Therapy on Postoperative Surgical Pain After Uni- and Bilateral Inguinal Hernia Repair. Phase 1
Recruiting NCT01090219 - Polypropylene Meshes in Hernia Repair N/A